Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00888
|
|||||
| Drug Name |
Pilocarpine
|
|||||
| Synonyms |
(+)-Pilocarpine; (3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one; (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one; (3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone; (3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone; (3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone; 3-Ethyl-4-(3-methyl-3H-imidazol-4-ylmethyl)dihydrofuran-2-one; 3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydro-2(3H)-furanone; 3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one; 3-ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydro-2(3H)-furanone; 3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one; Adsorbocarpine; Almocarpine; Amistura P; Diocarpine (TN); Epicar; Imidazole-5-butyric acid, alpha-ethyl-beta-(hydroxymethyl)-1-methyl-, gamma-lactone; Isopilocarpine; Isopto Carpine (TN); Isopto carpine; Isoptocarpine; Mi-Pilo; Minims Pilocarpine; Miocarpine; Miocarpine (TN); Ocu-Carpine; Ocusert; Ocusert P 20;Beta-Pilocarpine hydrochloride; Ocusert Pilo-20 (TN); Ocusert Pilo-40; Ocusert pilo; Ocusert pilo-20; Ocusert pilo-20 (TN); P.V. Carpine Liquifilm; Pilagan; Pilocarpin; Pilocarpine (JAN/USP); Pilocarpine (TN); Pilocarpine HCl; Pilocarpine Mononitrate, (3S-cis)-Isomer; Pilocarpine [USAN:BAN:JAN]; Pilocarpine chloride; Pilocarpine nitrate; Pilocarpine, Monohydrochloride, (3S-cis)-Isomer; Pilocarpol; Pilokarpin; Pilokarpol; Pilopine HS (TN); Piloptic-1; Piloptic-1/2; Piloptic-2; Piloptic-3; Piloptic-4; Piloptic-6; Pilostat; Salagen; Salagen (TN); Scheinpharm (TN); Spersacarpine; Syncarpine; Timpilo (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Cholinergic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C11H16N2O2
|
|||||
| Canonical SMILES |
CCC1C(COC1=O)CC2=CN=CN2C
|
|||||
| InChI |
InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1
|
|||||
| InChIKey |
QCHFTSOMWOSFHM-WPRPVWTQSA-N
|
|||||
| CAS Number |
CAS 54-71-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 208.26 | Topological Polar Surface Area | 44.1 | ||
| Heavy Atom Count | 15 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
1.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:8207
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.